278 Results

People

  1. Schwartz
    Schwartz
  2. Larson
    Larson
  3. Gonen
    Gonen
  4. Scher
    Scher
  5. Scheinberg
    Scheinberg
  6. Mcdevitt
    Mcdevitt
  7. Ginsberg
    Ginsberg
  8. Morris
    Morris
  9. Schoder
    Schoder
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (278)
  2. Radiology, Department of (278)
  3. Solid Tumor Oncology Division (178)
  4. GSK Faculty (147)
  5. Sloan Kettering Institute Faculty (116)
  6. Body Imaging Service (113)
  7. Molecular Pharmacology and Chemistry Program Faculty (113)
  8. Hematologic Malignancies, Division of (101)
  9. Molecular Imaging and Therapy Service (92)
  10. Epidemiology and Biostatistics (89)
  1. "controlled study"
  2. "Department of Medicine"
  3. "Radiology, Department of"
Formats
  1. Journal Article (274)
  2. Conference Paper (2)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (278)
  2. Radiology, Department of (278)
  3. Solid Tumor Oncology Division (178)
  4. GSK Faculty (147)
  5. Sloan Kettering Institute Faculty (116)
  6. Body Imaging Service (113)

More Groups

People
  1. Steven Larson (59)
  2. Lawrence Schwartz (36)
  3. Mithat Gonen (33)
  4. Howard Scher (28)
  5. David Scheinberg (25)
  6. Michael Mcdevitt (23)

More People

Years
  1. 2024 (5)
  2. 2023 (10)
  3. 2022 (7)
  4. 2021 (6)
  5. 2020 (12)
  6. 2019 (8)

More Years

Publications
  1. Clinical Cancer Research (29)
  2. Journal of Clinical Oncology (24)
  3. Journal of Nuclear Medicine (18)
  4. Cancer Research (11)
  5. Radiology (8)
  6. Blood (6)

More Publications

Publishers
  1. American Association for Cancer Research (43)
  2. American Society of Clinical Oncology (26)
  3. Springer (24)
  4. Elsevier Inc. (23)
  5. Society of Nuclear Medicine (18)
  6. Nature Publishing Group (15)

More Publishers

Results (278)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Management of pericardial effusion in patients with solid tumor: An algorithmic, multidisciplinary approach results in reduced mortality after paradoxical hemodynamic instability
    Journal Article

    Choe, J. K.; Byun, A. J.; Robinson, E.; Drake, L.; Tan, K. S.; McAleer, E. P.; Schaffer, W. L.; Liu, J. E.; Chen, L. L.; Buchholz, T.; more...
    Annals of Surgery (2024)

    Fulltext@MSK | Save
  • Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
    Journal Article

    Kurtz, K.; Eibler, L.; Dacek, M. M.; Carter, L. M.; Veach, D. R.; Lovibond, S.; Reynaud, E.; Qureshy, S.; McDevitt, M. R.; Bourne, C.; more...
    Theranostics (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save